Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @seQureLS
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @seQureLS
-
seQure Life Sciences proslijedio/la je Tweet
To contribute to the global response to the outbreak of the novel
#coronavirus infections, EMA is taking concrete actions to accelerate the development and availability of medicinal products for the treatment and prevention of the new coronavirus:https://www.ema.europa.eu/en/news/ema-support-development-vaccines-treatments-novel-coronavirus …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
Recently, we outlined our approach to expediting development & availability of critical medical products to prevent, diagnose, & treat 2019-nCoV using all applicable regulatory authorities to respond to this outbreak.https://go.usa.gov/xdBkE
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The European Medicines Agency has published the highlights for 2019 regarding medicinal products for human use. Find the list of highlights here: https://www.gmp-compliance.org/gmp-news/medicinal-products-for-human-use-emas-highlights-2019 …
#medicines#healthcarepic.twitter.com/grhQM4Zce4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
European Commission Calls for Observers to Join Annex XVI Subgroup |
#Regulatory Focushttps://ift.tt/3aWqmN1Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
EMA, MHRA Post Last-Minute Brexit Information |
#Regulatory Focushttps://ift.tt/2u9BaqrHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
CHMP Recommends 15 Medicines, Extends Six Indications |
#Regulatory Focushttps://ift.tt/36N1ILFHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are thrilled to announce that we will attend "Giornata di Studio AFI - Farmacovigilanza & Affari Regolatori" in Milan next week! Are you also joining this event? http://www.afiscientifica.it/eventi-afi/giornata-studio-afi-farmacovigilanza-affari-regolatori/ …pic.twitter.com/lSQiDsbc3f
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
A new
@precisionFDA challenge is now live! The purpose is to advance techniques for surveillance and detection of adverse events associated with FDA products. For more information and to get started, visit https://precision.fda.gov/challenges/9 pic.twitter.com/otsxIwXmuk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
EMA’s human medicines committee (
#CHMP) recommends 15#medicines for approval at its January 2020 meeting: https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-27-30-january-2020 …pic.twitter.com/xqCDIRAAYr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Have you already read the key principles of a harmonised approach to develop and use electronic product information (
#ePI) in the European Union? Learn more about this document on@EMA_News's website: https://www.ema.europa.eu/en/news/key-principles-use-electronic-product-information-eu-medicines …#medicinespic.twitter.com/rwCx5nv5CF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
First oral GLP-1 treatment for type 2
#diabetes recommended for approval. It provides patients with an option to treat the disease without injections https://www.ema.europa.eu/en/news/first-oral-glp-1-treatment-type-2-diabetes …#CHMPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
UK withdrawal from the EU on 31 January 2020: During the transition period, EU pharmaceutical law will continue to be applicable to the UK, meaning that pharmaceutical companies can continue to carry out activities in the UK until the end of the year.
https://www.ema.europa.eu/en/news/uk-withdrawal-eu-31-january-2020 …pic.twitter.com/KwuQoHMBE8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@EMA_News has released a statement, outlining the future for the UK’s#pharmaceutical industry in the transition period following#Brexit and thereafter:https://www.europeanpharmaceuticalreview.com/news/111816/ema-announces-next-steps-for-uk-pharma-industry-after-brexit/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@US_FDA published a new guideline on Adaptive Design Clinical Trials for#Drugs and#Biologics. The guidance describes important principles for designing, conducting, and reporting the results from an adaptive CT: https://www.gmp-compliance.org/gmp-news/fdas-advice-for-sponsors-of-adaptive-design-clinical-trials …#clinicaltrialspic.twitter.com/PA09mYrIDm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
First treatment for
#AcuteHepaticPorphyria, a rare life-threatening genetic condition, recommended for approval https://www.ema.europa.eu/en/news/first-treatment-acute-hepatic-porphyria …#CHMPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
On April 1, 2020, the
@US_FDA will hold a public meeting, Communications About the Safety of Medical Devices. During this meeting, we plan to discuss the development, content & format of the FDA’s safety communications for medical devices: https://go.usa.gov/xdTdh pic.twitter.com/gkN3Ou9DbgHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Have you already seen the latest World Health Organization Pharmaceuticals Newsletter? Download it together with previous issues from the WHO website: https://www.who.int/medicines/publications/newsletter/en/ …
#medicines#pharmaceuticalspic.twitter.com/NtpOAwLqgY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PM Holding, a group of service providers in the Life Sciences industry that include Arithmos, CROS NT and seQure Life Sciences, announces the appointment of Jan Back as Marketing Director. Welcome, Jan! http://sequrelifesciences.com/jan-back-marketing-director-pmh/ …
#lifesciences#careeropportunitiespic.twitter.com/lOE4EMG57F
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
seQure Life Sciences proslijedio/la je Tweet
What's on the agenda of the January meeting of EMA's human medicines committee https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-agenda-27-30-january-2020-meeting_en.pdf …
#CHMPHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our pharmacovigilance team keeps growing! We are thrilled to announce that Michael Obispo Torres has just joined us as Safety Data Manager. Excited to have you with us, Michael!
#lifesciences#career#pharmacovigilancepic.twitter.com/yIiv4z4HVO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.